Bunkerhill Health today announced it has received U.S. Food and Drug Administration (FDA) clearance for ECG-EF, an artificial intelligence algorithm that detects reduced left ventricular ejection ...
Get insights on the upcoming HOPE 3 phase 3 trial, key endpoints, and investment risks for CAPR. Learn what to watch in ...
MedPage Today on MSN
Hybrid Device for Heart Failure Shows Early Promise
The novel dual-function cardiac contractility modulation-defibrillator (CCM-D) for heart failure with reduced ejection fraction (HFrEF) had favorable early results in the Integra-D trial. The Integra ...
A new study shows targeted training may improve heart function, even in people already at risk of heart disease.
Women's heart health presents unique challenges due to anatomical differences, hormonal influences, and distinct symptom ...
Background Hospitalisation with acute heart failure (AHF) carries a high risk of death, and those surviving to discharge ...
Ad feature presented by WomenHeart. Heart disease can affect women of any age and, globally, it is the leading cause of death ...
Background Sudden cardiac death (SCD) is a common cause of cardiovascular mortality, often triggered by ventricular ...
The European Society of Cardiology has recently published guidelines regarding the management of pericarditis and myocarditis.
Choosing the right baler machine is a big step for any farm looking to get more done with less hassle. It’s not just about squashing down hay or straw; it’s ...
A scientific statement regarding HF with preserved ejection fraction in patients with cancer and cancer survivors has been published by the ESC.
BACKGROUND: PYGM (muscle glycogen phosphorylase), the rate-limiting enzyme in glycogenolysis, plays an indispensable role in maintaining cardiac energy metabolism. However, the role of PYGM in the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results